{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:48:41Z","timestamp":1785426521703,"version":"3.56.0"},"reference-count":47,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"UCB Pharma,and C\u00e9dric Laloyaux"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1002\/jcph.678","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T10:27:26Z","timestamp":1449052046000},"page":"852-861","source":"Crossref","is-referenced-by-count":94,"title":["A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain"],"prefix":"10.1002","volume":"56","author":[{"given":"Olivier","family":"Rascol","sequence":"first","affiliation":[{"name":"Clinical Investigation Center CIC1436 and Department of Clinical Pharmacology and Neurosciences, INSERM; Toulouse University Hospital and University of Toulouse; Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Zesiewicz","sequence":"additional","affiliation":[{"name":"University of South Florida Ataxia Research Center, The Frances J. Zesiewicz Foundation for Parkinson's Disease at USF, Parkinson's Disease and Movement Disorders Clinic at the PADREC; James A. Haley Veterans' Administration; Tampa FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Ray","family":"Chaudhuri","sequence":"additional","affiliation":[{"name":"National Parkinson's Foundation International Centre of Excellence; King's College Hospital; Kings College and Kings Health Partners; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Asgharnejad","sequence":"additional","affiliation":[{"name":"UCB Pharma; Raleigh NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Surmann","sequence":"additional","affiliation":[{"name":"UCB Pharma; Monheim am Rhein; Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Dohin","sequence":"additional","affiliation":[{"name":"UCB Pharma; Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Nilius","sequence":"additional","affiliation":[{"name":"UCB Pharma; Monheim am Rhein; Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bauer","sequence":"additional","affiliation":[{"name":"UCB Pharma; Monheim am Rhein; Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,12,31]]},"reference":[{"issue":"11","key":"10.1002\/jcph.678-BIB0001|jcph678-cit-0001","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s40263-012-0005-2","article-title":"Management of pain in Parkinson's disease","volume":"26","author":"Sophie","year":"2012","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1002\/jcph.678-BIB0002|jcph678-cit-0002","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.clineuro.2013.08.022","article-title":"Pain in Parkinson's disease: analysis and literature review","volume":"115","author":"Rana","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"10.1002\/jcph.678-BIB0003|jcph678-cit-0003","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/mds.24054","article-title":"Prevalence of pain in Parkinson's disease: a systematic review using the modified QUADAS tool","volume":"27","author":"Broen","year":"2012","journal-title":"Mov Disord"},{"key":"10.1002\/jcph.678-BIB0004|jcph678-cit-0004","doi-asserted-by":"crossref","first-page":"304203","DOI":"10.1155\/2014\/304203","article-title":"Pain in Parkinson's disease associated with COMT gene polymorphisms","volume":"2014","author":"Li","year":"2014","journal-title":"Behav Neurol"},{"issue":"2","key":"10.1002\/jcph.678-BIB0005|jcph678-cit-0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10072-014-1942-y","article-title":"Parkinson's disease patients with pain suffer from more severe non-motor symptoms","volume":"36","author":"Mao","year":"2015","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1002\/jcph.678-BIB0006|jcph678-cit-0006","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrneurol.2012.54","article-title":"Pains in Parkinson's disease-many syndromes under one umbrella","volume":"8","author":"Wasner","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1002\/jcph.678-BIB0007|jcph678-cit-0007","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00702-012-0915-7","article-title":"The epidemiology of pain in Parkinson's disease","volume":"120","author":"Defazio","year":"2013","journal-title":"J Neural Transm"},{"issue":"4","key":"10.1002\/jcph.678-BIB0008|jcph678-cit-0008","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mds.23959","article-title":"Pain in Parkinson's disease","volume":"27","author":"Ha","year":"2012","journal-title":"Mov Disord"},{"issue":"1","key":"10.1002\/jcph.678-BIB0009|jcph678-cit-0009","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s00415-012-6754-5","article-title":"Parkinson's disease related pain: a review of recent findings","volume":"260","author":"Truini","year":"2013","journal-title":"J Neurol"},{"issue":"11","key":"10.1002\/jcph.678-BIB0010|jcph678-cit-0010","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/mds.23135","article-title":"Parkinson's disease symptoms: the patient's perspective","volume":"25","author":"Politis","year":"2010","journal-title":"Mov Disord"},{"key":"10.1002\/jcph.678-BIB0011|jcph678-cit-0011","article-title":"Sensory abnormalities and pain in Parkinson's disease and its modulation by treatment of motor symptoms","author":"Cury","year":"2015","journal-title":"Eur J Pain"},{"issue":"3","key":"10.1002\/jcph.678-BIB0012|jcph678-cit-0012","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.parkreldis.2012.11.009","article-title":"Pain in Parkinson's disease: a review of the literature","volume":"19","author":"Fil","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"10.1002\/jcph.678-BIB0013|jcph678-cit-0013","first-page":"63","article-title":"Pain in Parkinson's disease","volume":"5","author":"Ford","year":"1998","journal-title":"Clin Neurosci"},{"issue":"Suppl 1)","key":"10.1002\/jcph.678-BIB0014|jcph678-cit-0014","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1002\/mds.22716","article-title":"Pain in Parkinson's disease","volume":"25","author":"Ford","year":"2010","journal-title":"Mov Disord"},{"issue":"5","key":"10.1002\/jcph.678-BIB0015|jcph678-cit-0015","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1002\/jcph.678-BIB0016|jcph678-cit-0016","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/mds.22142","article-title":"Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey","volume":"23","author":"N\u00e8gre-Pag\u00e8s","year":"2008","journal-title":"Mov Disord"},{"issue":"2","key":"10.1002\/jcph.678-BIB0017|jcph678-cit-0017","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mds.22932","article-title":"Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser-evoked potentials","volume":"25","author":"Tinazzi","year":"2010","journal-title":"Mov Disord"},{"issue":"5","key":"10.1002\/jcph.678-BIB0018|jcph678-cit-0018","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/clpt.2011.301","article-title":"Likert Pain Score modeling: A Markov integer model and an autoregressive continuous model","volume":"91","author":"Plan","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1002\/jcph.678-BIB0019|jcph678-cit-0019","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.pain.2011.07.005","article-title":"Validity of four pain intensity rating scales","volume":"152","author":"Ferreira-Valente","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/jcph.678-BIB0020|jcph678-cit-0020","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jpainsymman.2010.08.016","article-title":"Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review","volume":"41","author":"Hjermstad","year":"2011","journal-title":"J Pain Symptom Manage"},{"issue":"12","key":"10.1002\/jcph.678-BIB0021|jcph678-cit-0021","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/mds.26270","article-title":"King's Parkinson's disease pain scale, the first scale for pain in PD: an international validation","volume":"30","author":"Chaudhuri","year":"2015","journal-title":"Mov Disord"},{"issue":"1","key":"10.1002\/jcph.678-BIB0022|jcph678-cit-0022","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00210-008-0341-4","article-title":"The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease","volume":"379","author":"Scheller","year":"2009","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"10.1002\/jcph.678-BIB0023|jcph678-cit-0023","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.clinthera.2012.02.008","article-title":"Steady-state plasma concentration profile of transdermal rotigotine: an integrated analysis of three, open-label, randomized, phase I multiple dose studies","volume":"34","author":"Elshoff","year":"2012","journal-title":"Clin Ther"},{"issue":"5","key":"10.1002\/jcph.678-BIB0024|jcph678-cit-0024","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40265-015-0377-y","article-title":"An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson's disease and restless legs syndrome","volume":"75","author":"Elshoff","year":"2015","journal-title":"Drugs"},{"issue":"6","key":"10.1002\/jcph.678-BIB0025|jcph678-cit-0025","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1474-4422(07)70108-4","article-title":"Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial","volume":"6","author":"Poewe","year":"2007","journal-title":"Lancet Neurol"},{"issue":"16","key":"10.1002\/jcph.678-BIB0026|jcph678-cit-0026","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1212\/01.wnl.0000259516.61938.bb","article-title":"Advanced Parkinson's disease treated with rotigotine transdermal system: PREFER Study","volume":"68","author":"LeWitt","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/jcph.678-BIB0027|jcph678-cit-0027","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3233\/JPD-130320","article-title":"A randomized study of rotigotine dose response on \u201coff\u201d time in advanced Parkinsons disease","volume":"4","author":"Nicholas","year":"2014","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"10.1002\/jcph.678-BIB0028|jcph678-cit-0028","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/archneur.64.5.676","article-title":"Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson's disease","volume":"64","author":"Jankovic","year":"2007","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1002\/jcph.678-BIB0029|jcph678-cit-0029","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000252355.79284.22","article-title":"Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson's disease","volume":"68","author":"Watts","year":"2007","journal-title":"Neurology"},{"issue":"16","key":"10.1002\/jcph.678-BIB0030|jcph678-cit-0030","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/mds.21741","article-title":"Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole","volume":"22","author":"Giladi","year":"2007","journal-title":"Mov Disord"},{"issue":"1","key":"10.1002\/jcph.678-BIB0031|jcph678-cit-0031","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.23441","article-title":"Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER)","volume":"26","author":"Trenkwalder","year":"2011","journal-title":"Mov Disord"},{"issue":"10","key":"10.1002\/jcph.678-BIB0032|jcph678-cit-0032","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/ene.12757","article-title":"Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms-results of a double-blind, randomized, placebo-controlled trial","volume":"22","author":"Antonini","year":"2015","journal-title":"Eur J Neurol"},{"issue":"Suppl 1)","key":"10.1002\/jcph.678-BIB0033|jcph678-cit-0033","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1007\/PL00007730","article-title":"PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures","volume":"245","author":"Peto","year":"1998","journal-title":"J Neurol"},{"issue":"6","key":"10.1002\/jcph.678-BIB0034|jcph678-cit-0034","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond AS","year":"1983","journal-title":"Acta Psychiatr Scand"},{"issue":"7","key":"10.1002\/jcph.678-BIB0035|jcph678-cit-0035","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mds.10473","article-title":"The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations","volume":"18","author":"MDS Task Force on Rating Scales for Parkinson's Disease","year":"2003","journal-title":"Mov Disord"},{"key":"10.1002\/jcph.678-BIB0036|jcph678-cit-0036","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2377-14-42","article-title":"Rotigotine transdermal system and evaluation of pain in patients with Parkinson's disease: a post hoc analysis of the RECOVER study","volume":"14","author":"Kassubek","year":"2014","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1002\/jcph.678-BIB0037|jcph678-cit-0037","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pain.2009.08.019","article-title":"Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations","volume":"146","author":"Dworkin","year":"2009","journal-title":"Pain"},{"issue":"2","key":"10.1002\/jcph.678-BIB0038|jcph678-cit-0038","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"issue":"3","key":"10.1002\/jcph.678-BIB0039|jcph678-cit-0039","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1002\/jcph.678-BIB0040|jcph678-cit-0040","unstructured":"Schwarz J Kassubek J Oehlwein C A multicenter, non-interventional study with rotigotine to evaluate the perception of pain associated with idiopathic Parkinson's disease: the NEUPAD study"},{"issue":"12","key":"10.1002\/jcph.678-BIB0041|jcph678-cit-0041","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/mds.20629","article-title":"Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study","volume":"20","author":"Brefel-Courbon","year":"2005","journal-title":"Mov Disord"},{"issue":"10","key":"10.1002\/jcph.678-BIB0042|jcph678-cit-0042","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/jnnp.2007.120212","article-title":"Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study","volume":"78","author":"Gerdelat-Mas","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1002\/jcph.678-BIB0043|jcph678-cit-0043","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/jamaneurol.2015.8","article-title":"An 8-year follow-up on the effect of subthalamic nucleus deep brain stimulation on pain in Parkinson's disease","volume":"72","author":"Jung","year":"2015","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1002\/jcph.678-BIB0044|jcph678-cit-0044","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1007\/s00415-015-7823-3","article-title":"Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson's disease patients with chronic pain","volume":"262","author":"Madeo","year":"2015","journal-title":"J Neurol"},{"issue":"12","key":"10.1002\/jcph.678-BIB0045|jcph678-cit-0045","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S1474-4422(15)00243-4","article-title":"Prolonged release oxycodone\/naloxone for the treatment of severe Parkinson's disease-related pain: PANDA-a double-blind, randomized, placebo-controlled study","volume":"14","author":"Trenkwalder","year":"2015","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1002\/jcph.678-BIB0046|jcph678-cit-0046","doi-asserted-by":"crossref","first-page":"e0130492","DOI":"10.1371\/journal.pone.0130492","article-title":"Cognition and the placebo effect-dissociating subjective perception and actual performance","volume":"10","author":"Schwarz","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1002\/jcph.678-BIB0047|jcph678-cit-0047","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.neuron.2014.02.042","article-title":"Placebo analgesia: a predictive coding perspective","volume":"81","author":"Buchel","year":"2014","journal-title":"Neuron"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.678","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jcph.678\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T13:03:20Z","timestamp":1657803800000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,31]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.678","archive":["Portico"],"relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12,31]]}}}